Skip to main content
    C

    Cadrenal Therapeutics, Inc. Common Stock (CVKD)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.88
    +0.48 (+34.29%)

    Market Cap: $4.34M

    Last updated: Nov 17, 2026 at 4:43 PM ET

    Cadrenal Therapeutics, Inc. Common Stock (CVKD) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Cadrenal Therapeutics, Inc. Common Stock (CVKD) has a market cap of $4.34M and an enterprise value of $1.28M. Its share count is up 98.56% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 70.45% below the market cap, as cash exceeds debt.

    Market Cap$4.34M
    Enterprise Value$1.28M
    Latest price (Nov 17, 2026)$1.88

    Key Dates

    The next earnings report is expected on Mar 29, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 29, 2027 (expected)
    Last Earnings DateAug 13, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 39.32% in the quarter ended Sep 30, 2026 and grew 91.74% a year over 2 years.

    Shares Outstanding4.06M
    Shares Change (YoY)+98.56%
    Shares Change (QoQ)+39.32%
    Share Count Growth (2Y CAGR)+91.74%

    Price Statistics

    The stock is down 83.81% over 52 weeks and trades 70.91% above its 50-day average.

    Beta (1Y)1.76
    52-Week Change-83.81%
    1-Month Change+77.36%
    3-Month Change+14.63%
    6-Month Change-62.17%
    Total Return (1Y)-83.81%
    Total Return (3Y CAGR)-35.45%
    Return vs SPY (1Y)-95.80%
    Max Drawdown (1Y)-92.90%
    Max Drawdown (3Y)-96.80%
    Sharpe Ratio (1Y)-1.65
    Correlation with SPY (1Y)0.22
    50-Day Average$1.10
    200-Day Average$3.58
    52-Week Range$0.82 to $12.50
    RSI (14 Days)76.4
    Average Volume (20 Days)110.33K

    Price chart

    Financial Position

    Current assets cover 6.26x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio6.26x
    Quick Ratio6.26x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -347.86% and return on assets is -292.37% over the last 12 months.

    Return on Equity (ROE)-347.86%
    Return on Assets (ROA)-292.37%

    Scores

    CVKD has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Gross Profit-$555
    Operating Income-$10.19M
    Pretax Income-$10.10M
    Net Income-$10.10M
    Reported EPS (TTM)-$4.90

    Trailing 12 months through Sep 30, 2026.

    Balance Sheet

    Shareholder equity funds 83.82% of the $3.46M in total assets.

    Cash and Equivalents$3.06M
    Total Debt$0
    Net Cash$3.06M
    Net Cash Per Share$0.75
    Working Capital$2.90M
    Shareholder Equity$2.90M
    Book Value Per Share$0.72
    Total Assets$3.46M
    Total Liabilities$551.34K

    Balance sheet as of Sep 30, 2026.

    Cash Flow

    Operating Cash Flow-$9.72M
    FCF Per Share-$2.73
    Depreciation and Amortization$2.01K

    Trailing 12 months through Sep 30, 2026.

    Growth

    Book Value Per Share Growth (2Y CAGR)-60.63%
    Tangible Book Per Share Growth (2Y CAGR)-60.63%

    Dividends and Yields

    CVKD does not pay a dividend.

    Buyback Yield-86.48%
    Shareholder Yield-86.48%

    Stock Splits

    The last split was a 1-for-15 reverse split on Aug 20, 2024.

    Last Split DateAug 20, 2024
    Split TypeReverse split
    Split Ratio1:15

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About CVKD

    What is CVKD's market cap?

    Cadrenal Therapeutics, Inc. Common Stock has a market cap of $4.34M. Its enterprise value, which adds debt and subtracts cash, is $1.28M.

    How many shares of CVKD are outstanding?

    Cadrenal Therapeutics, Inc. Common Stock has 4.06M shares outstanding. The count is up 98.56% from a year earlier.

    Does CVKD pay a dividend?

    No. Cadrenal Therapeutics, Inc. Common Stock does not pay a dividend.

    How much debt does CVKD have?

    Cadrenal Therapeutics, Inc. Common Stock has $0 of total debt and $3.06M of cash and equivalents, a net cash position of $3.06M.